全文获取类型
收费全文 | 9715篇 |
免费 | 509篇 |
国内免费 | 29篇 |
专业分类
耳鼻咽喉 | 129篇 |
儿科学 | 650篇 |
妇产科学 | 140篇 |
基础医学 | 852篇 |
口腔科学 | 195篇 |
临床医学 | 774篇 |
内科学 | 2627篇 |
皮肤病学 | 243篇 |
神经病学 | 507篇 |
特种医学 | 318篇 |
外科学 | 1331篇 |
综合类 | 267篇 |
预防医学 | 417篇 |
眼科学 | 342篇 |
药学 | 574篇 |
中国医学 | 16篇 |
肿瘤学 | 871篇 |
出版年
2023年 | 42篇 |
2021年 | 293篇 |
2020年 | 143篇 |
2019年 | 189篇 |
2018年 | 280篇 |
2017年 | 150篇 |
2016年 | 172篇 |
2015年 | 206篇 |
2014年 | 295篇 |
2013年 | 366篇 |
2012年 | 542篇 |
2011年 | 564篇 |
2010年 | 332篇 |
2009年 | 254篇 |
2008年 | 437篇 |
2007年 | 508篇 |
2006年 | 489篇 |
2005年 | 415篇 |
2004年 | 409篇 |
2003年 | 338篇 |
2002年 | 338篇 |
2001年 | 277篇 |
2000年 | 246篇 |
1999年 | 230篇 |
1998年 | 143篇 |
1997年 | 85篇 |
1996年 | 87篇 |
1995年 | 80篇 |
1994年 | 47篇 |
1993年 | 64篇 |
1992年 | 172篇 |
1991年 | 180篇 |
1990年 | 171篇 |
1989年 | 160篇 |
1988年 | 165篇 |
1987年 | 138篇 |
1986年 | 120篇 |
1985年 | 123篇 |
1984年 | 112篇 |
1983年 | 77篇 |
1982年 | 54篇 |
1981年 | 45篇 |
1980年 | 42篇 |
1979年 | 82篇 |
1978年 | 39篇 |
1977年 | 64篇 |
1976年 | 40篇 |
1974年 | 49篇 |
1972年 | 48篇 |
1970年 | 43篇 |
排序方式: 共有10000条查询结果,搜索用时 218 毫秒
51.
52.
53.
54.
55.
Skeletal effects of calcitonin in ovariectomized rats 总被引:3,自引:0,他引:3
T J Wronski C F Yen K W Burton R C Mehta P S Newman E E Soltis P P DeLuca 《Endocrinology》1991,129(4):2246-2250
Although calcitonin (CT) has been shown to be effective for the prevention of bone loss in early postmenopausal women, the skeletal effects of the hormone specifically during the early stages of estrogen deficiency have not been characterized histomorphometrically to date. The current study involves use of the ovariectomized (OVX) rat as an animal model for early postmenopausal bone loss to perform such a histomorphometric analysis. One group of OVX rats was injected sc with salmon CT on alternate days for a 6-week period. Additional groups of OVX and sham-operated control rats were treated with vehicle alone. In comparison to control rats, the proximal tibia of vehicle-treated OVX rats were characterized by a 3-fold decrease in cancellous bone volume and significant increases in osteoblast surface (+200%), osteoclast surface (+143%), mineralizing surface (+111%), mineral apposition rate (+36%), bone formation rate (+181%), and longitudinal bone growth (+38%). In contrast, treatment of OVX rats with CT normalized tibial cancellous bone volume and significantly decreased all of the above cellular- and fluorochrome-based indices of bone turnover to near control levels. The results indicate that CT treatment depresses bone turnover and prevents the development of osteopenia in OVX rats. These findings are consistent with the bone protective effect of CT in early postmenopausal women and further support the OVX rat as an animal model for the preclinical evaluation of prophylactic treatments for postmenopausal bone loss. 相似文献
56.
57.
58.
H K Mehta 《The British journal of ophthalmology》1989,73(7):488-493
Fifteen patients with suspected malignant lesions of the lower eyelids or inner canthal region, needing large excisions, were managed as day cases with spontaneous repair and simultaneous subtotal primary surgical reconstruction under local anaesthesia. For lesions confined to the lower eyelid, only those patients requiring full-thickness margin-inclusive (FTMI) excisions of more than half the horizontal extent of the eyelid are included in this study-the largest excision being 21 x 6 mm. For malignant lesions of the inner canthus, only those patients needing moderate to large excision of inner canthal skin and orbicularis with simultaneous FTMI excision of the medial one-third (8 x 5 mm) of the upper as well as the lower eyelid are included. The 16th patient had traumatic loss of inner canthal tissue. The final cosmetic and functional results in all 16 patients were satisfactory and comparable with the results of competent and in-toto primary surgical reconstructions. For large excisions at the inner canthus spontaneous with partial primary surgical repair allows the use of a less extensive and less elaborate surgical procedure that is within the capabilities of most ophthalmic surgeons. 相似文献
59.
60.
The potential of topoisomerase I inhibitors in the treatment of CNS malignancies: report of a synergistic effect between topotecan and radiation 总被引:1,自引:0,他引:1
Summary Despite innovations in imaging, surgery, and radiation therapy, local failure remains the principle clinical problem in most CNS malignancies. To date, chemotherapy has not made a major impact in the treatment of most adult CNS tumors. The inroads made by chemotherapy in pediatric CNS malignancies suggest that novel drugs, or drug combinations, may improve therapy. Topoisomerase I (Topo I) inhibitors are a relatively new group of chemotherapy drugs with a novel mechanism of action. Drugs in this group currently undergoing clinical trials are the Camptothecin analogues Topotecan, CPT-11, and 9-aminocamptothecin. There is substantial preclinical and some clinical evidence to suggest that these drugs could be useful in the treatment of CNS malignancies. Preclinical studies with the water soluble Topo I inhibitor, Topotecan, demonstrate antineoplastic activity in a variety of CNS malignancies. In addition, Topotecan has good CNS penetration in primates, and recent preliminary phase I and II clinical trials of Topotecan in pediatric and adult CNS malignancies have been promising. In this paper, we describe the unique mechanism of action, antineoplastic activity, and radiosensitizing properties of Topo I inhibitors. We present the first report demonstrating potentiation of radiation lethality by Topotecan in a human glioma (1354) cell line. The dose enhancement ratio was 3.2 at 10% survival. Thus, there is evidence to suggest that Topo I inhibitors may be beneficial in the treatment of CNS neoplasms on the basis of their antineoplastic activity alone, as well as their radiosensitizing effects. Two clinical trials which utilize concurrent Topotecan and radiation in the treatment of pediatric and adult CNS malignancies are discussed. 相似文献